BioArctic and Eisai presented latest data regarding lecanemab at AD/PD 2021 |
| March 15, 2021 | March 2021 Bond Updates |
|
STOCKHOLM, March 15, 2021 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced data on the drug candidate lecanemab (BAN2401), which were presented by the company and its partner Eisai at the 15th International Conference on Alzheimer's and Parkinson's Diseases... |
| View more at: https://www.prnewswire.com:443/news-releases/bioarctic-and-eisai-presented-latest-data-regarding-lecanemab-at-adpd-2021-301247102.html |
| Related News |